当前位置:
X-MOL 学术
›
Eur. Heart J.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Targeted antiplatelet therapy: novel treatment options for ischaemic heart disease
European Heart Journal ( IF 39.3 ) Pub Date : 2017-10-06 , DOI: 10.1093/eurheartj/ehx559 Meinrad Gawaz , Oliver Borst
European Heart Journal ( IF 39.3 ) Pub Date : 2017-10-06 , DOI: 10.1093/eurheartj/ehx559 Meinrad Gawaz , Oliver Borst
This editorial refers to ‘A single-chain antibody-CD39 fusion protein targeting activated platelets protects from cardiac ischaemia/reperfusion injury’†, by M. Ziegler et al., on page 111.
中文翻译:
靶向抗血小板治疗:缺血性心脏病的新治疗选择
M. Ziegler等人在这篇社论中提到“靶向活化血小板的单链抗体-CD39融合蛋白可预防心肌缺血/再灌注损伤” † 。,在第111页。
更新日期:2017-10-06
中文翻译:
靶向抗血小板治疗:缺血性心脏病的新治疗选择
M. Ziegler等人在这篇社论中提到“靶向活化血小板的单链抗体-CD39融合蛋白可预防心肌缺血/再灌注损伤” † 。,在第111页。